BIOPIA is a non-profit collaborative effort of European laboratories with expertise in biopharmaceutical pharmacokinetics and immunogenicity. It is a spin-off initiative from the ABIRISK consortium that aims to raise awareness about immunogenicity and the integration of testing drug levels and anti-drug antibodies (ADA) as a measure to improve the quality of patients’ treatment. BIOPIA involves several labs from all across Europe that specialise in biotherapeutical immunogenicity and assessing drug serum levels in many diseases. Through this website, we will work together to:

  • Provide easy, accessible information about ADA and drug level testing
  • Create a site for clinicians to help them assess biologic responses in their patients and choose the correct treatment for each person
  • Connect European labs and hospitals together, with the goal of implementing routine, clinical testing for immunogenicity and drug levels